Integrated BioFoundry DBTL: BioFoundry (ultrahigh-speed microbial breeding) DBTL: Elementary technology utilization Scale-up process development In-house product development Intestinal microbiome model
A startup leveraging its proprietary language processing technology, SATOMI®, to support the automatic generation of medical records and referral letters. By streamlining information use in clinical settings, it promotes regional collaboration and medical DX, contributing to the development of a sustainable healthcare system.
A startup developing artificial red blood cells coated with a lipid bilayer. These cells possess oxygen-carrying capacity equivalent to red blood cells and enable long-term storage, aiming to revolutionize transfusion medicine through stable blood transfusions in veterinary medicine and future practical application in human healthcare.
We are conducting clinical development of an oral therapeutic cancer vaccine. We have completed a Phase I clinical trial targeting urothelial carcinoma and are currently conducting a Phase I/IIa clinical trial for malignant pleural mesothelioma.
At Beef Sommelier, we provide our B-som Diagnosis with the aim of creating a world where producers can raise their ideal cattle and consumers can enjoy beef that truly matches their preferences. Our technology not only quantifies biological information from beef cattle, but also supports producers in achieving their target meat quality. By introducing a new scientific perspective that goes beyond conventional standards, we make the “unseen qualities” of beef visible and measurable. This enables consumers to clearly understand the characteristics of the beef they choose. B-som is the world’s first scientific diagnostic service that bridges the gap between producers and consumers.